Your browser doesn't support javascript.
loading
METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance.
Zhang, Ye; Qiu, Jian-Ge; Jia, Xiao-Yu; Ke, Yu; Zhang, Ming-Kun; Stieg, David; Liu, Wen-Jing; Liu, Ling-Zhi; Wang, Lin; Jiang, Bing-Hua.
Afiliação
  • Zhang Y; Academy of Medical Science, School of Basic Medical Science, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou, 450008, China.
  • Qiu JG; Academy of Medical Science, School of Basic Medical Science, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou, 450008, China.
  • Jia XY; Academy of Medical Science, School of Basic Medical Science, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou, 450008, China.
  • Ke Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
  • Zhang MK; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
  • Stieg D; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Liu WJ; Academy of Medical Science, School of Basic Medical Science, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou, 450008, China; Department of Pathology, Anatomy & Cell Biology, Sidney Kimmel Cancer Center, Thomas Jefferson Universi
  • Liu LZ; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
  • Wang L; Academy of Medical Science, School of Basic Medical Science, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou, 450008, China. Electronic address: wanglinzz@zzu.edu.cn.
  • Jiang BH; Academy of Medical Science, School of Basic Medical Science, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou, 450008, China. Electronic address: binghjiang@zzu.edu.cn.
Cancer Lett ; 553: 215971, 2023 01 28.
Article em En | MEDLINE | ID: mdl-36257380
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Resistencia a Medicamentos Antineoplásicos / Proteínas de Filamentos Intermediários / Metiltransferases Limite: Animals / Female / Humans Idioma: En Revista: Cancer Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Irlanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Resistencia a Medicamentos Antineoplásicos / Proteínas de Filamentos Intermediários / Metiltransferases Limite: Animals / Female / Humans Idioma: En Revista: Cancer Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Irlanda